| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |